"Schizophrenia" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A severe emotional disorder of psychotic depth characteristically marked by a retreat from reality with delusion formation, HALLUCINATIONS, emotional disharmony, and regressive behavior.
| Descriptor ID |
D012559
|
| MeSH Number(s) |
F03.700.750
|
| Concept/Terms |
Schizophrenia- Schizophrenia
- Schizophrenias
- Schizophrenic Disorders
- Disorder, Schizophrenic
- Disorders, Schizophrenic
- Schizophrenic Disorder
- Dementia Praecox
|
Below are MeSH descriptors whose meaning is more general than "Schizophrenia".
Below are MeSH descriptors whose meaning is more specific than "Schizophrenia".
This graph shows the total number of publications written about "Schizophrenia" by people in this website by year, and whether "Schizophrenia" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1992 | 1 | 1 | 2 |
| 1993 | 1 | 0 | 1 |
| 1996 | 2 | 0 | 2 |
| 1997 | 1 | 0 | 1 |
| 1998 | 1 | 0 | 1 |
| 1999 | 4 | 0 | 4 |
| 2000 | 1 | 0 | 1 |
| 2001 | 4 | 0 | 4 |
| 2002 | 5 | 0 | 5 |
| 2003 | 3 | 0 | 3 |
| 2004 | 1 | 0 | 1 |
| 2005 | 2 | 2 | 4 |
| 2006 | 2 | 0 | 2 |
| 2007 | 2 | 0 | 2 |
| 2008 | 6 | 1 | 7 |
| 2009 | 6 | 0 | 6 |
| 2010 | 4 | 0 | 4 |
| 2011 | 3 | 0 | 3 |
| 2012 | 3 | 1 | 4 |
| 2013 | 4 | 0 | 4 |
| 2014 | 6 | 1 | 7 |
| 2015 | 3 | 0 | 3 |
| 2016 | 6 | 1 | 7 |
| 2017 | 3 | 1 | 4 |
| 2018 | 1 | 0 | 1 |
| 2020 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Schizophrenia" by people in Profiles.
-
McEvoy JP, Kremens DE. Early Recognition and Treatment of Tardive Dyskinesia in Patients With Mood Disorders and Schizophrenia. J Clin Psychiatry. 2020 Jan 28; 81(1).
-
Correll CU, Lauriello J. Long-Acting Injectable Antipsychotics: Where Do They Fit in the Treatment Plan? J Clin Psychiatry. 2018 Jan/Feb; 79(1).
-
Foster A, Buckley P, Lauriello J, Looney S, Schooler N. Combination Antipsychotic Therapies: An Analysis From a Longitudinal Pragmatic Trial. J Clin Psychopharmacol. 2017 Oct; 37(5):595-599.
-
Aine CJ, Bockholt HJ, Bustillo JR, Cañive JM, Caprihan A, Gasparovic C, Hanlon FM, Houck JM, Jung RE, Lauriello J, Liu J, Mayer AR, Perrone-Bizzozero NI, Posse S, Stephen JM, Turner JA, Clark VP, Calhoun VD. Multimodal Neuroimaging in Schizophrenia: Description and Dissemination. Neuroinformatics. 2017 Oct; 15(4):343-364.
-
Rahman T, Ash DM, Lauriello J, Rawlani R. Misleading Guidance From Pharmacogenomic Testing. Am J Psychiatry. 2017 Oct 01; 174(10):922-924.
-
Pillai A, Schooler NR, Peter D, Looney SW, Goff DC, Kopelowicz A, Lauriello J, Manschreck T, Mendelowitz A, Miller DD, Severe JB, Wilson DR, Ames D, Bustillo J, Kane JM, Buckley PF. Predicting relapse in schizophrenia: Is BDNF a plausible biological marker? Schizophr Res. 2018 03; 193:263-268.
-
Karathanasis N, Tsamardinos I, Lagani V. omicsNPC: Applying the Non-Parametric Combination Methodology to the Integrative Analysis of Heterogeneous Omics Data. PLoS One. 2016; 11(11):e0165545.
-
Gerken AT, McGahee S, Keuroghlian AS, Freudenreich O. Consideration of Clozapine and Gender-Affirming Medical Care for an HIV-Positive Person with Schizophrenia and Fluctuating Gender Identity. Harv Rev Psychiatry. 2016 Nov/Dec; 24(6):406-415.
-
Buckley PF, Schooler NR, Goff DC, Kopelowicz A, Lauriello J, Manschreck TC, Mendelowitz A, Miller DD, Wilson DR, Ames D, Bustillo JR, Kane JM, Looney SW. Comparison of Injectable and Oral Antipsychotics in Relapse Rates in a Pragmatic 30-Month Schizophrenia Relapse Prevention Study. Psychiatr Serv. 2016 12 01; 67(12):1370-1372.
-
Gragnoli C, Reeves GM, Reazer J, Postolache TT. Dopamine-prolactin pathway potentially contributes to the schizophrenia and type 2 diabetes comorbidity. Transl Psychiatry. 2016 Apr 19; 6:e785.